Quanterix, Sony DADC to Develop and Manufacture Consumables for SiMoA Platform | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quanterix and Sony DADC Austria today announced an agreement to develop and manufacture "smart consumables" for Quanterix's technology platform for the life sciences and in vitro diagnostic markets.

The companies are partnering on production of the Quanterix Single Molecule Array, or SiMoA, Discs, which would be the first diagnostic consumables with assay technology based on optical disc formats by Sony DADC, the two firms said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.